Dermatology

>

Latest News

FDA approves pz-cel for recessive dystrophic epidermolysis bullosa | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves pz-cel for recessive dystrophic epidermolysis bullosa

April 29th 2025

The decision makes pz-cel the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with RDEB.

FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up

April 18th 2025

FDA approves maralixibat tablet formulation for ALGS and PFIC | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves maralixibat tablet formulation for ALGS and PFIC

April 14th 2025

JNJ-2113 for plaque psoriasis demonstrates clear skin in 75% of adolescents | Image Credit: © Ban - © Ban - stock.adobe.com.
JNJ-2113 for plaque psoriasis demonstrates clear skin in 75% of adolescents

April 10th 2025

Uncharacteristic skin findings in a toddler with a history of dermatitis
Uncharacteristic skin findings in a toddler with a history of dermatitis

April 8th 2025

Video Interviews
Podcasts
stock image of a hemangioma

More News

© 2025 MJH Life Sciences

All rights reserved.